Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia

Viatris · Product launch · October 16, 2026

The U.S. Food and Drug Administration approved RYZUMVI, a phentolamine ophthalmic solution, for treating presbyopia in adults.

Read the announcement

AntSpace’s summary of Viatris’s own announcement: read the original.

More updates from Viatris